The market entry of biosimilars to Humira^® (adalimumab) is long-awaited. These products have the potential to improve affordability in the near- and...

As we enter 2023, David Fields is sharing his top forecasts and takeaways for plan sponsors and the PBM industry.

As we continue our employee spotlight series, we are excited to highlight Shelly McAdoo, Navitus’ new Diversity, Equity and Inclusion (DEI) Senior...

Navitus’ Vice President of Government Relations, Robyn Crosson, shares her insight into the Inflation Reduction Act and how it will impact our...

This week we provide an overview of our 2021 drug trend and client savings with insights for 2022 and beyond.

In a new series of spotlight posts featuring our employees, we sat down with Dr. Julie Olson to hear about her recent promotion to vice president of...

Carrie Aiken, Navitus’ Vice President of Corporate Compliance and Chief Compliance Officer, shares her perspective on how PBMs can help plan sponsors...

Sharon Faust, PharmD, Vice President of Specialty Pharmacy for Lumicera shares a few key initiatives that will continue to create an impact for...

As a member, plan sponsor or consultant, do you understand what the new federal guidance on free at-home COVID-19 tests means to you? As part of...

Know everything you need to know about protecting your organization from pharmacy benefit fraud, waste and abuse? Chances are you don't - that's why...

Navitus’ CEO, David Fields, shares his insights into the pharmacy benefits industry that will help plan sponsors achieve greater cost savings,...

Plans can leverage population health management programs to achieve better health outcomes. Learn a few best practices in today’s blog.